MOZART THERAPEUTICS
LIVE

Serial Number

97518221

Owner

Mozart Therapeutics, Inc.

Attorney

Connie Ellerbach

Filing Date

Jul 25, 2022

Add to watchlist:

No watchlists yet
View on USPTO

MOZART THERAPEUTICS Trademark

Serial Number: 97518221

MOZART THERAPEUTICS is a trademark filed by Mozart Therapeutics, Inc. on July 25, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Mozart Therapeutics, Inc. (2 trademarks)

410 W Harrison Street, Suite 150
Seattle, WA 98119

Entity Type: 03

Trademark Details

Filing Date

July 25, 2022

Registration Date

Not Registered

Published for Opposition

August 13, 2024

Goods & Services

Pharmaceutical products and preparations for the prevention and treatment of diseases and disorders, namely, autoimmune diseases and disorders, inflammatory diseases and disorders, infectious diseases and disorders, cancer, and gastrointestinal diseases and disorders; biological products, namely, preparations for the prevention and treatment of diseases and disorders, namely, autoimmune diseases and disorders, inflammatory diseases and disorders, gastrointestinal diseases and disorders, infectious diseases and disorders, and cancer; cell therapy products, namely, preparations for the prevention and treatment of diseases and disorders, namely, autoimmune diseases and disorders, inflammatory diseases and disorders, gastrointestinal diseases and disorders, infectious diseases and disorders, and cancer; therapeutic products, namely, preparations for the prevention and treatment of diseases and disorders, namely, autoimmune diseases and disorders, inflammatory diseases and disorders, gastrointestinal diseases and disorders, infectious diseases and disorders, and cancer; pharmaceutical products and preparations for the treatment and prevention diseases and disorders, namely, autoimmune diseases and disorders, inflammatory diseases and disorders, gastrointestinal diseases and disorders, infectious diseases and disorders, and cancer; biological products, namely, preparations for the treatment and prevention diseases and disorders, namely, autoimmune diseases and disorders, inflammatory diseases and disorders, gastrointestinal diseases and disorders, infectious diseases and disorders, and cancer; cell therapy products, namely preparations for the treatment and prevention diseases and disorders, namely, autoimmune diseases and disorders, inflammatory diseases and disorders, gastrointestinal diseases and disorders, infectious diseases and disorders, and cancer; therapeutic and medicinal products, namely, preparations for the treatment and prevention diseases and disorders, namely, autoimmune diseases and disorders, inflammatory diseases and disorders, gastrointestinal diseases and disorders, infectious diseases and disorders, and cancer; diagnostic biomarker reagents for use in diagnosing, preventing, and treating diseases and disorders, namely, autoimmune diseases and disorders, inflammatory diseases and disorders, gastrointestinal diseases and disorders, infectious diseases, and cancer; diagnostic agents, preparations, and substances for use in diagnosing, preventing, and treating diseases and disorders, namely, autoimmune diseases and disorders, inflammatory diseases and disorders, infectious diseases and disorders, cancer, and gastrointestinal diseases and disorders

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 13, 2026 EXRA
SOU EXTENSION 3 GRANTED
Feb 12, 2026 EX3G
SOU EXTENSION 3 FILED
Feb 12, 2026 EXT3
SOU TEAS EXTENSION RECEIVED
Feb 12, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 10, 2025 EXRA
SOU EXTENSION 2 GRANTED
Sep 9, 2025 EX2G
SOU EXTENSION 2 FILED
Sep 9, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Sep 9, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 27, 2025 EXRA
SOU EXTENSION 1 GRANTED
Mar 26, 2025 EX1G
SOU EXTENSION 1 FILED
Mar 26, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Mar 26, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 8, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 13, 2024 NPUB
PUBLISHED FOR OPPOSITION
Aug 13, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 24, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 10, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 30, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 29, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 29, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 1, 2023 GNRN
NON-FINAL ACTION E-MAILED
Jun 1, 2023 GNRT
NON-FINAL ACTION WRITTEN
Jun 1, 2023 CNRT
ASSIGNED TO EXAMINER
May 10, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 29, 2022 NWOS
NEW APPLICATION ENTERED
Jul 28, 2022 NWAP